Ignite Creation Date:
2024-05-06 @ 7:25 PM
Last Modification Date:
2024-10-26 @ 3:06 PM
Study NCT ID:
NCT06007846
Status:
RECRUITING
Last Update Posted:
2023-09-21
First Post:
2023-07-26
Brief Title:
A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer
Sponsor:
Inova Health Care Services
Organization:
Inova Health Care Services
Study Overview
Official Title:
A Prospective Cohort Study of Single Agent Memantine in Patients With Child-Pugh Score B7 Cirrhosis and Hepatocellular Carcinoma
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a single-site prospective study to describe efficacy endpoints of single agent memantine in patients with unresectable locally advanced or metastatic HCC otherwise not deemed candidates for intensive systemic therapy In addition to the primary endpoint and multiple secondary efficacy endpoints we will describe changes in quality of life on treatment over time
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None